Rachel Lindsey Croft

age ~34

from Marina, CA

Get Report

Also known as:

Rachel L Croft

Phone and address:: 289 Reservation Rd APT A, Marina, CA 93933

Connected to:

Rachel Croft Phones & Addresses

289 Reservation Rd APT A, Marina, CA 93933
Seaside, CA
San Jose, CA
2076 Jonathan Ave, San Jose, CA 95125

Work

Position:

Medical Professional

Us Patents

Unified Systems And Methods For Controlling Use And Operation Of A Family Of Different Treatment Devices
view source
US Patent:

6783523, Aug 31, 2004
Filed:

Aug 5, 2002
Appl. No.:

10/212311
Inventors:

Jay Qin - Fremont CA
Robin Bek - Campbell CA
John Gaiser - Mountain View CA
Rachel Croft - San Francisco CA
Peter Muller - Los Gatos CA
David S Utley - Redwood City CA
Assignee:

Curon Medical, Inc. - Fremont CA
International Classification:

A61B 1900
US Classification:

606 1, 606 41
Abstract:

Unified systems and methods enable control of the use and operation of a family of different treatment devices, to treat dysfunction in different regions of the body.

Systems And Methods For Applying A Selected Treatment Agent Into Contact With Tissue To Treat Disorders Of The Gastrointestinal Tract
view source
US Patent:

6790207, Sep 14, 2004
Filed:

Nov 26, 2001
Appl. No.:

09/994375
Inventors:

David S. Utley - San Carlos CA
John W Gaiser - Mountain View CA
Rachel Croft - San Francisco CA
Assignee:

Curon Medical, Inc. - Fremont CA
International Classification:

A61B 1818
US Classification:

606 41, 128898, 607133
Abstract:

Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.

Systems And Methods For Applying A Selected Treatment Agent Into Contact With Tissue To Treat Sphincter Dysfunction
view source
US Patent:

6802841, Oct 12, 2004
Filed:

Nov 26, 2001
Appl. No.:

09/994379
Inventors:

David S Utley - San Carlos CA
John W Gaiser - Mountain View CA
Rachel Croft - San Francisco CA
Assignee:

Curon Medical, Inc. - Fremont CA
International Classification:

A61B 1818
US Classification:

606 41, 128898, 607133
Abstract:

Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.

Systems And Methods For Treating Dysfunctions In The Intestines And Rectum
view source
US Patent:

7056320, Jun 6, 2006
Filed:

Sep 29, 2003
Appl. No.:

10/674242
Inventors:

David Utley - San Carlos CA, US
Scott West - Livermore CA, US
John Gaiser - Mountain View CA, US
Rachel Croft - San Francisco CA, US
Assignee:

Curon Medical, Inc. - Fremont CA
International Classification:

A61B 18/18
US Classification:

606 41, 128898
Abstract:

A sphincter tissue region is treated using a support structure sized for advancement into the anal canal. At least one electrode is carried by the structure. A mechanism is coupled to the electrode to move the electrode between a first position retracted in the support structure and a second position extended from the support structure through surface tissue to penetrate a subsurface tissue region at or near a sphincter in the anal canal. A cable is coupled to the electrode to conduct energy for application by the electrode to form a lesion in the subsurface tissue region.

Systems And Methods For Applying A Selected Treatment Agent Into Contact With Tissue To Treat Disorders Of The Gastrointestinal Tract
view source
US Patent:

7293563, Nov 13, 2007
Filed:

Aug 5, 2004
Appl. No.:

10/912268
Inventors:

David Utley - San Carlos CA, US
John W Gaiser - Mountain View CA, US
Rachel Croft - San Francisco CA, US
Assignee:

Curon Medical, Inc. - Fremont CA
International Classification:

A61B 19/00
US Classification:

128898, 606 41, 607133
Abstract:

Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.

Systems Methods For Applying A Selected Treatment Agent Into Contact With Tissue To Treat Sphincter Dysfunction
view source
US Patent:

7458378, Dec 2, 2008
Filed:

Aug 5, 2004
Appl. No.:

10/912329
Inventors:

David S Utley - San Carlos CA, US
John W Gaiser - Mountain View CA, US
Rachel Croft - San Francisco CA, US
Assignee:

Respiratory Diagnostics, Inc. - Redmond WA
International Classification:

A61B 19/00
A61B 18/18
US Classification:

128898, 606 41, 607133
Abstract:

Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.

Systems And Methods For Treating Obesity And Other Gastrointestinal Conditions
view source
US Patent:

7468060, Dec 23, 2008
Filed:

Nov 8, 2002
Appl. No.:

10/291862
Inventors:

David S. Utley - Redwood City CA, US
Rachel E. Croft - San Francisco CA, US
John Gaiser - Mountain View CA, US
Assignee:

Respiratory Diagnostic, Inc. - Redmond WA
International Classification:

A61B 18/18
A61N 1/00
US Classification:

606 41, 607133, 128898
Abstract:

Systems and methods affect tightening of the pyloric sphincter and/or serve to mediate or moderate receptive relaxation of muscles in the stomach, to treat or mitigate various physiologic conditions, such as obesity, biliary reflex, GERD, and/or Barrett's esophagus. The systems and methods may be used as either a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.

Method For Treating Fecal Incontinence
view source
US Patent:

7699844, Apr 20, 2010
Filed:

Jun 5, 2006
Appl. No.:

11/446771
Inventors:

David Utley - San Carlos CA, US
Scott West - Livermore CA, US
John Gaiser - Mountain View CA, US
Rachel Croft - San Francisco CA, US
Assignee:

Mederi Therapeutics, Inc. - Cos Cob CT
International Classification:

A61B 18/18
US Classification:

606 41, 128898
Abstract:

A sphincter tissue region is treated using a support structure sized for advancement into the anal canal. At least one electrode is carried by the structure. A mechanism is coupled to the electrode to move the electrode between a first position retracted in the support structure and a second position extended from the support structure through surface tissue to penetrate a subsurface tissue region at or near a sphincter in the anal canal. A cable is coupled to the electrode to conduct energy for application by the electrode to form a lesion in the subsurface tissue region.